Revealing the role of tumor-educated platelets in cancer: insights into thrombosis, metastasis and? therapy?
Scientific-Disciplinary Group
05/BIOS-09 - Clinical Biochemistry And Clinical Molecular Biology, 05/BIOS-10 - Cellular And Experimental Biology, 06/MEDS-05 - Internal Medicine, 06/MEDS-09 - Blood Diseases, Oncology And Rheumatology
Description
Cancer-associated thrombosis (CAT) increases the risk of blood clots in cancer patients and contributes to metastasis through complex interactions involving endothelial dysfunction, platelet activation, inflammation, and hypercoagulation. This study investigates how lung cancer reshapes the tumor microenvironment into a pro-thrombotic and pro-metastatic niche, focusing on mitochondrial reprogramming driven by aberrant NF-kB/IkB-alpha signaling. These metabolic alterations promote endothelial activation, platelet conversion into tumor-educated platelets (TEPs), and increased von Willebrand factor release. Using in vitro and in vivo models, the project will examine platelet–tumor interactions, identify specific platelet signatures, and assess the therapeutic potential of targeting TEPs. The findings aim to uncover biomarkers and novel strategies to counteract thrombosis and metastasis in lung cancer patients.
Compensation
22,500 Euro
Job posting website
Number of positions
1
Maximum duration
24.0
Funding body
Università di Torino
How to apply
Selection process
Click to expand
View the original posting on the MUR website: Go to MUR website